Topical foscarnet vs placebo
Adverse effects ‐ application site reaction · participants with recurrent herpes labialis
Topical foscarnet showed no clear difference in adverse effects during use of the preventative intervention… compared with placebo (moderate certainty).
1 finding from 1 review
- Interventions for prevention of herpes simplex labialis (cold sores on the lips) 2015 · Cochrane Headline outcomes onlyRR 2.47 [0.79, 7.69]1 study · 302 participantsModerate